Table 1 Anticancer drugs and drug targets.

TargetDrugNo. of cancer clinical trials
CASP31541BPreclinical
PAC-13
HDAC6Citarinostat5
Ricolinostat10
MAPK14 (p38α)Ralimetinib5
SCIO-4693
PAK4PF-037583091
PBK (TOPK)OTS514Preclinical
OTS964Preclinical
PIM1SGI-17762